• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

Advertisement

Organisation › Details

Vermillion Inc. (Nasdaq: VRML)

Vermillion, Inc. (formerly Ciphergen Biosystems, Inc.) is dedicated to the discovery, development and commercialization of novel high-value diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. Vermillion, along with its prestigious scientific collaborators, has ongoing diagnostic programs in oncology/hematology, cardiology and women's health with an initial focus in ovarian cancer. Based in Fremont, California. *

 

	Start	2006-08-15 renamed date ca
	Group	Vermillion (Group)
	Industry	molecular diagnostics
	Industry 2	protein chip product (array, bead, lab-on-a-chip)
	Region	Austin, TX
	Country	United States (USA)
	Street	6611 Bee Caves Road
	City	78738 Austin, TX
	Tel	+1-512-519-0400
	Fax	+1-512-439-6980
		Address record changed: 2011-01-22
Basic data	Employees	n. a.
	Currency	USD
	Annual sales	44,000 (revenue, consolidated (2007) 2007-12-31)
	Profit	-21,300,000 (2007-12-31)
	Cash	8,283,000 (2008-03-31)
		* Document for »About Section«: Vermillion, Inc.. (8/24/07). "Press Release: Vermillion (formerly Ciphergen) Announces $20.5 Million Private Placement of Common Stock". Fremont, CA.
		Record changed: 2011-12-25

More documents for Vermillion (Group)

• [1] Bonislawski, Adam. (12/23/11). "News: Vermillion Shareholder Alleges Medicare Denying over 80 Percent of OVA1 Reimbursement Claims"....
• [2] Bonislawski, Adam. (12/2/11). "News: Court Approves Sale of Correlogic’s Assets to Vermillion after Second Bidder Drops Out"....
• [3] Vermillion, Inc.. (11/9/11). "Press Release: Vermillion Reports Results for Third Quarter 2011". Austin, TX....
• [4] Vermillion, Inc.. (8/3/11). "Press Release: Vermillion Appoints Distribution Partner for OVA1 in Israel and the Palestine Territories". Austin, TX....
• [5] Vermillion, Inc.. (4/4/11). "Press Release: Vermillion and Quest Diagnostics Sign Agreement to Make OVA1 Available in India. Data Presented at IGCS Meeting New Delhi". Austin, TX....
• [6] Vermillion, Inc.. (2/2/11). "Press Release: Vermillion Announces Notice of Allowance of Patent for Breast Cancer Biomarkers". Austin, TX....
• [7] Vermillion, Inc.. (1/22/10). "Press Release: Vermillion Emerges from Bankruptcy. Company Poised to Launch OVA1". Fremont, CA....
• [8] Vermillion, Inc.. (12/4/09). "Press Release: Vermillion Files Amended Plan of Reorganization and Exchanges Debt". Fremont, CA....
• [9] Pronota N.V.. (6/18/07). "Press Release: Pronota Strenghtens Commercial Team with Appointment of Business Development Director". Ghent....
• [10] Correlogic Systems Inc.. (6/6/07). "Press Release: Correlogic Systems and JEOL Sign Research and Development Agreement. Joint Efforts to Advance Clinical Application of Mass Spectrometry". Rockville, MD....

To subscribe to our free, monthly [MSC] Newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

NEW: Visit our brand new forthcoming web portals Life-Sciences-Germany.com and Life-Sciences-Europe.com

» top

» Imprint  |  » Contact  |  The use of this website requires to accept the disclaimer!   |  A project of [iito] Business Intelligence © 2002-2012. Made in Germany.